Literature DB >> 28394954

[Risk factors for the development of lung cancer in a cohort of adult smokers].

Fernando Saldías Peñafiel1, José Manuel Elola Aránguiz1, Javier Uribe Monasterio1, Arturo Morales Soto1, Orlando Díaz Patiño1.   

Abstract

BACKGROUND: Identifying risk factors for lung cancer in the population could improve the cost-effectiveness of early detection programs using thoracic computed tomography (CT). AIM: To examine the risk factors of lung cancer in a cohort of adult smokers. PATIENTS AND METHODS: An annual clinical and respiratory functional assessment, chest computed tomography for three years and clinical follow up for five years was carried out in 270 patients aged 65 ± 9 years, 55% males, active or former smokers of 10 or more pack-years.
RESULTS: Thirty seven percent of patients were active smokers, consuming 37 ± 26 packs/year, 85% had comorbidities, especially chronic obstructive pulmonary disease (COPD) (66%), hypertension (48%), diabetes (22%) and dyslipidemia (42%). Thirteen percent of patients had family history of lung cancer. Twenty-one cases of lung cancer were detected in the five years follow up, especially squamous cell carcinoma and adenocarcinoma. In the univariate analysis, the main risk factors for lung cancer identified were an age older than 60 years, history of COPD, family history of lung cancer, active smoking, tobacco consumption more than 30 pack/year and lung hyperinflation. In multivariate analysis, the three independent risk factors for lung cancer were a family history of lung cancer, active smoking and the number of packs per year of tobacco consumption.
CONCLUSIONS: The identification of risk groups probably will improve the performance of programs for early detection of lung cancer.

Entities:  

Mesh:

Year:  2016        PMID: 28394954     DOI: 10.4067/S0034-98872016001100003

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  3 in total

1.  Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.

Authors:  Koichi Ogawa; Yasuhiro Koh; Hiroyasu Kaneda; Motohiro Izumi; Yoshiya Matsumoto; Kenji Sawa; Mitsuru Fukui; Yoshihiko Taniguchi; Naoki Yoshimoto; Akihiro Tamiya; Masahiko Ando; Akihito Kubo; Shun-Ichi Isa; Hideo Saka; Akihide Matsumura; Tomoya Kawaguchi
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

2.  Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.

Authors:  Tsai-Hui Lin; Shu-I Chen; Yuan-Chih Su; Mei-Chen Lin; Hung-Jen Lin; Sheng-Teng Huang
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

3.  CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis.

Authors:  Biao Li; Qing Yuan; Yu-Ting Zou; Ting Su; Qi Lin; Yu-Qing Zhang; Wen-Qing Shi; Rong-Bin Liang; Qian-Min Ge; Qiu-Yu Li; Yi Shao
Journal:  J Cancer       Date:  2020-02-20       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.